Symposia and Learning Theaters

Industry-Supported CME Breakfast and Lunch Symposia

Industry-Supported CME Symposia will be offered during morning timeslots from 5:45 AM to 7:15 AM, and during lunch on Sunday, October 7, from 11:45 AM – 1:00 PM. These accredited CME programs are not associated with the CHEST Annual Meeting. All CME Satellite Breakfast and Lunch Symposia are taking place at the Marriott Rivercenter, 101 Bowie St, San Antonio, Texas, 78205.

Disclaimer: These symposia are not supported, endorsed, or accredited by the American College of Chest Physicians.

5:45 AM – 7:15 AM
Severe Uncontrolled Asthma: Assessing Phenotypic-driven Approaches to Treatment
Salon CDE
Provided by Vindico Medical Education. This educational activity is supported by an educational grant from GlaxoSmithKline.
11:45 AM – 1:00 PM
Advancing the Care of Patients with SSc-ILD: Accurate Diagnosis, Improved Risk Assessment, and Evidence-based Disease Management
Salon ABF
Provider: Integrity Continuing Education, Inc. This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Rethink, Redefine, and Retool: Shifting the Paradigm in CABP
Salon HLK
Provided by Medscape Education. Supported by an educational grant from Nabriva.

Personalized Medicine in Nontuberculous Mycobacteria: Best Practices in Diagnosing and Managing NTM
Salon IJ
Provider: National Jewish Health. This activity is supported by an educational grant from Insmed Incorporated.

Challenging Cases in PH: You Decide the Outcome
Salon CDE
Provided by TotalCME, Inc. Accredited by Postgraduate Institute for Medicine. This activity is supported by independent educational grants from Actelion Pharmaceuticals US, Inc.

5:45 AM – 7:15 AM

Addressing Unmet Medical Needs for Patients with COPD
Salon ABF
Provided by ASiM. This educational activity is supported by an educational grant from GlaxoSmithKline.

Clinical Implications of Emerging Data: Diagnosis and Treatment of ILD with a Progressive Lung Disease Phenotype
Salon IJ
Provider: National Jewish Health. This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies
Salon CDE
This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. This activity is supported by an independent educational grant from AstraZeneca LP.

5:45 AM – 7:15 AM

Utilizing the Molecular/Physiologic Phenotype to Direct Asthma Therapy: A Comprehensive 3-Dimensional Study
Salon CDE
Provided by the Med Learning Group. Supported by an educational grant from Sanofi Regeneron.

Long-Acting Agents in Severe COPD: Evidence-Based Strategies for Selection
Salon ABF
Provided by Medscape Education. Supported by an independent educational grant from GlaxoSmithKline.

Integrating Emerging Evidence to Improve Recognition, Diagnosis, Early Intervention, and Long-term Management of Progressive Fibrosing Interstitial Lung Disease
Salon IJ
Provider: Paradigm Medical Communications, LLC. This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Updates in Inoperable CTEPH
Salon HLK
Provided by the France Foundation. Supported by an educational grant from Actelion Pharmaceuticals US, Inc.

5:45 AM – 7:15 AM

Updates in Precision Medicine: Elevating the Treatment of Severe, Eosinophilic Asthma
Salon CDE
Provider: Annenberg Center for Health Sciences. This educational activity is supported by an educational grant from GlaxoSmithKline.This educational activity is supported by an independent educational grant from AstraZeneca.

Patient Pathways in PAH: Cases and Considerations Across the Spectrum of Disease
Salon IJ
Provided by Medscape. Supported by educational grants from Actelion and United Therapeutics.

Updates in IPF and Related Fibrotic Lung Diseases: Expanding Applications for Existing Therapies
Salon ABF
This continuing medical education activity is provided by Vindico Medical Education. This activity is supported by an independent medical education grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Learning Theater Presentations in the Exhibit Hall

Learning Theater presentations give industry an opportunity to present information on specific disease states to CHEST attendees in a mini-theater setting within the Exhibit Hall. Presentations will be held on Monday and Tuesday. Critical Care Skills Product Workshops will be held on Wednesday.

The learning theater workshops will take place at the Henry Gonzalez Convention Center Exhibit Hall in theaters 1-3. For more detailed information, please check the CHEST Events app.

10:15 – 11:00 AM

Learning Theater 1
“The First LAMA for Inhalation Using Natural Breathing”
Sponsored by Sunovion Pharmaceuticals Inc.

Learning Theater 2
“From Discussion to Diagnosis: Improving the IPF Patient Journey”
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

Learning Theater 3
“Connecting Type 2 Cytokines to Airway Pathology in Uncontrolled Asthma”
Sponsored by Sanofi Gynzyme and Regeneron

12:30 – 1:15 pm

Learning Theater 1
“Severe Asthma and a Targeted Treatment Approach”
Sponsored by AstraZeneca

Learning Theater 2
“REDUCING EXACERBATION RISK EARLY IN COPD: Exploring the evidence”
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

Learning Theater 3
“Idiopathic Pulmonary Fibrosis: A Closer Look at the Patient Journey”
Sponsored by Genentech, A Member of the Roche Group

2:30 – 3:15 pm

Learning Theater 1
“Novel Approaches to Lung Nodule Management”
Sponsored by Veracyte

Learning Theater 2
“Redefining Severe Uncontrolled Asthma: Exploring the Role of Eosinophils as a Mechanism of Disease”
Sponsored by AstraZeneca

Learning Theater 3
“GIAPREZA (angiotensin II): A Novel Treatment Option for Distributive Shock”
Sponsored by La Jolla Pharmaceuticals

10:15 – 11:00 AM

Learning Theater 1
“The First LAMA for Inhalation Using Natural Beathing”
Sponsored by Sunovion Pharmaceuticals Inc.

Learning Theater 2
“Advanced Sarcoidosis: Who is at risk?”
Sponsor by Mallinckrodt Pharmaceuticals

Learning Theater 3
“COPD Exacerbations in Relationship to Peripheral Blood Eosinophil Levels—Potential Considerations for Treatment”
Sponsor by AstraZeneca

12:30 – 1:15 pm

Learning Theater 1
“Evaluating the Effect of LAMA/LABA and Triple (ICS/LABA/LAMA) Therapy on Patients With COPD”
Sponsored by GlaxoSmithKline 

Learning Theater 2
“GIAPREZA (angiotensin II): A Novel Treatment Option for Distributive Shock”
Sponsored by La Jolla Pharmaceutical Company

Learning Theater 3
“Long-Term Exacerbation Data in Severe Asthma”
Sponsored by GlaxoSmithKline

1:45 – 2:30 pm

Learning Theater 1
“More Than an Airway Problem? Understanding Excessive Sleepiness in Obstructive Sleep Apnea (OSA)”
Sponsored by Jazz Pharmaceuticals

Learning Theater 2
“AVYCAZ® (Ceftazidime and Avibactam): What Chest Physicians Should Know About the Latest Indication”
Sponsored by Allergan

Learning Theater 3
“Clinical Considerations for Nonmetastatic Stage III and Tissue Acquisition and Diagnostic Testing for Metastatic Stage IV Non-small Cell Lung Cancer”
Sponsored by AstraZeneca

12:30 – 1:15 pm

Learning Theater 1
“Humidified High Flow therapy: Reduction in acute exacerbation rate in COPD patients with chronic hypoxemic respiratory failure”
Sponsored by Fisher & Paykel Healthcare

Non-CME Dinner Symposia at the Marriott Rivercenter

Non-CME educational programs give industry a unique opportunity to present products and/or best practices as a workshop, special activity, poster presentation, reception, or other format to present branded or nonbranded information to CHEST attendees. Each symposium will take place at the Marriott Rivercenter.

6:00 – 8:00 PM

Idiopathic Pulmonary Fibrosis: Leading Experts Discuss the Latest Diagnostic Guidance and Treatment With OFEV® (Nintedanib)
Salon CDE

In this educational symposium, two expert pulmonologists will present information regarding idiopathic pulmonary fibrosis (IPF) and OFEV® (nintedanib). An expert faculty member will provide an overview of the disease, focusing on the updated diagnostic criteria for IPF. Patient case studies will be used to provide real-world examples of how the updated criteria will affect the diagnostic process. The speaker will also review recommendations for facilitating a multidisciplinary discussion as part of the diagnostic process. The second expert faculty will provide an overview of the OFEV® safety and efficacy data and discuss treatment benefits for patients with IPF.

Marilyn Glassberg, MD
Lucas Pitts, MD

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

6:00 – 10:00 PMPrecision Medicine and Severe Uncontrolled Asthma
Salon IJ

Please join our panel of esteemed experts as we discuss identification and management of patients with severe asthma in an interactive, case-based format. Attendees will gain an increased understanding of:

  • Identification of severe, uncontrolled asthma
  • Immunology of severe asthma
  • How patient phenotypes can help guide severe asthma management
  • New resources to aid clinicians in identifying and managing severe asthma
  • Processes and infrastructure involved in incorporating new therapies for severe asthma into clinical practice
  • Ongoing research in severe asthma

Monica Kraft, MD, FCCP (chair)
David Beuther, MD, FCCP
Eugene Bleecker, MD
Kevin Murphy, MD
Joan Reibman, MD, FCCP
Shyam Subramanian, MD, FCCP

Sponsored by AstraZeneca

6:00 – 8:15 PM

More Than Skin Deep: Partnering to Improve Early Diagnosis of Systemic Sclerosis-Associated Interstitial Lung Disease
Salon CDE

In this educational symposium, an expert pulmonologist and an expert rheumatologist will present information about recognizing and diagnosing systemic sclerosis-associated interstitial lung disease (SSc-ILD). The rheumatologist will provide an overview of SSc, using a case study to highlight the interactions that occur between the rheumatologist and the pulmonologist and the need for early involvement of a pulmonologist in this disease. The pulmonologist will discuss SSc-ILD and how the partnership with a rheumatologist evolves once a patient develops lung involvement.

Gregory P. Cosgrove, MD, FCCP
Aryeh Fischer, MD

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

6:00 – 10:00 PM

Genentech Lung Disease Symposium
Salon IJ

Join us for a discussion on current topics in asthma and idiopathic pulmonary fibrosis (IPF). This two-part program will feature expert speakers – two pulmonologists and a thoracic radiologist – specializing in the diagnosis and management of patients with allergic asthma or IPF.

Geoff Chupp, MD
Anoop Nambiar, MD, FCCP
Alison Wilcox, MD

Sponsored by Genentech, A Member of the Roche Group  

6:00 – 10:00 PM

Target Treatment in Eosinophilic Disease
Salon ABF

GSK invites you to an interactive program about the role of eosinophils in disease pathogenesis. Join us at this dinner program to discuss the benefits of targeted treatment in patients with an eosinophilic disease.

Mark Forshag, MD, FCCP

Sponsored by GSK 

6:00 – 10:00 PM 

Beyond the Crisis – the Role of Nebulization in Chronic Maintenance Therapy for COPD
Salon HLK

Beyond the Crisis – the Role of Nebulization in Chronic Maintenance Therapy for COPD is a 90-minute interactive symposium guided by experts in the management of patients with COPD and focused on the appropriate selection and use of inhaled devices.The Faculty will utilize patient cases to illustrate key concepts in COPD management including:

  • How and why pulmonologists’ and patients’ knowledge of and attitudes towards COPD, nebulizers, and other inhaled devices differ and how to overcome these differences
  • The rational for expanding the use of nebulizers beyond severe disease
  • Recommendations for appropriately pairing drug with device in specific clinical situations

Sidney S. Braman, MD, Master FCCP

This program is supported in part by an independent educational grant from Mylan Specialty, L.P. and Theravance Biopharma US, Inc.

Critical Care Skills: Hands-On Product Workshops

The American College of Chest Physicians is pleased to offer attendees and industry representatives the opportunity to participate in hands-on, non-CME product workshops at CHEST 2018. Gather information on new products, equipment, and services in a hands-on setting within the exhibit hall.

Presentations will be held in Learning Theater 2 on Wednesday, October 10.

10:15 – 11:00 am
Nasal High Flow: What Really Matters?

Outline the challenges associated with traditional oxygen therapy, review the findings from recent clinical studies and debate your implementation of Nasal High Flow for patients across the continuum of care.

Nicholas Hill, MD, PhD, FCCP
Chris Hutchinson – Senior Product Manager

Sponsored by Fisher & Paykel Healthcare